Durata greenshoe exercised for $57.56 million public offering of stock

8,222,500 common shares sold by BofA, Credit Suisse and Jefferies

By Devika Patel

Knoxville, Tenn., April 17 - Durata Therapeutics, Inc. said the underwriters for a public sale of stock opted to exercise the deal's $7.51 million greenshoe in full for total proceeds of $57.56 million. The offering priced on April 12.

The company sold 8,222,500 common shares at $7.00 per share. The price per share is a 3.85% discount to the April 11 closing share price of $7.28. Of the shares, 1,072,500 were part of the fully exercised greenshoe.

BofA Merrill Lynch, Credit Suisse Securities (USA) LLC and Jefferies LLC were the joint bookrunning managers.

The pharmaceutical company is based in Morristown, N.J.

Issuer:	Durata Therapeutics, Inc.
Issue:	Common stock
Amount:	$57,557,500 (including $7,507,500 greenshoe)
Shares:	8,222,500
Price:	$7.00
Warrants:	No
Bookrunners:	BofA Merrill Lynch, Credit Suisse Securities (USA) LLC and Jefferies LLC
Co-managers:	JMP Securities LLC and RBC Capital Markets, LLC
Pricing date:	April 12
Settlement date:	April 17
Stock symbol:	Nasdaq: DRTX
Stock price:	$7.28 at close April 11
Market capitalization:	$135.64 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.